Cost-Effectiveness and Cost-Utility of Intralesional Recombinant Human Epidermal Growth Factor for Adjuvant Treatment of Wagner’s 3 and 4 Diabetic Foot Ulcers

Saved in:
Bibliographic Details
Published in:Value in health 2016-11, Vol.19 (7), p.A673-A674
Main Authors: Romero Prada, ME, Vivas-Consuelo, D, Huerfano, LM, Alfonso Quiñones, PA, Roa Cardenas, NC, Acero, G
Format: Article
Language:English
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2016.09.1880